Publications by authors named "Edvard Abel"

Claim this Profile
C
Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III Trial.
Maria Gebre-Medhin, Gabriel Adrian, Per Engström, Hedda Haugen Cange, Lalle Hammarstedt-Nordenvall, Edvard Abel

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and outcome of genomics-guided treatment selection in advanced cancer - the MEGALiT explorative clinical trial.
Lars Ny, Henrik Fagman, Johan Botling, Loviisa Mantovaara, Peter Asplund, Edvard Abel

Acta Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Kjetil Taskén, Soemeya F Haj Mohammad, Gro Live Fagereng, Ragnhild Sørum Falk, Åslaug Helland, Edvard Abel

Acta Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial.
Ellen Backlund, Muyi Yang, Vitali Grozman, Giuseppe Masucci, Johan Falkenius, Edvard Abel

Acta Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatigue in Patients With Head and Neck Cancer Treated With Radiation Therapy: A Prospective Study of Patient-Reported Outcomes and Their Association With Radiation Dose to the Cerebellum.
Edvard Abel, Ewa Silander, Fredrik Nordström, Caroline Olsson, N Patrik Brodin

Adv Radiat Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer.
Maria Gebre-Medhin, Eva Brun, Per Engström, Hedda Haugen Cange, Lalle Hammarstedt-Nordenvall, Edvard Abel

J Clin Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Aspects of Quality of Life in Head and Neck Cancer Patients Treated With Intensity Modulated Radiation Therapy: A 5-Year Longitudinal Follow-up and Comparison with a Normal Population Cohort.
Edvard Abel, Ewa Silander, Jan Nyman, Thomas Björk-Eriksson, Eva Hammerlid

Adv Radiat Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial experience with introducing national guidelines for CT- and MRI-based delineation of organs at risk in radiotherapy.
Caroline Olsson, Tufve Nyholm, Elinore Wieslander, Eva Onjukka, Adalsteinn Gunnlaugsson, Edvard Abel

Phys Imaging Radiat Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of preoperative chemoradiotherapy for patients with advanced cancer of the nasal cavity and paranasal sinuses.
Erik Fernström, Jan Nyman, Eva Hammerlid, Erik Holmberg, Hedda Haugen-Cange, Edvard Abel

Acta Otolaryngol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact on quality of life of IMRT versus 3-D conformal radiation therapy in head and neck cancer patients: A case control study.
Edvard Abel, Ewa Silander, Jan Nyman, Mogens Bove, Leif Johansson

Adv Radiat Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiation.
Marie Kalm, Edvard Abel, Pontus Wasling, Jan Nyman, Max Albert Hietala

Int J Radiat Oncol Biol Phys· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer.
Bjørn H Grønberg, Tudor Ciuleanu, Øystein Fløtten, Aija Knuuttila, Edvard Abel

Lung Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis